The French Industrialist Betting on Robotics to Cure Disease (And the Ethical Line He Won’t Cross) | Ep. 316 with Hervé de Malliard President of Maison MGA

Episode notes

Daniel Robbins interviews Hervé de Malliard about the manufacturing mindset he learned while building industrial projects in China from 1994 to 1999 and how that shaped his approach to building complex engineered systems in healthcare. Hervé shares why Maison MGA focuses on integrating robotics and instrumentation into cleanroom environments to support life science workflows, and why TechBio will redefine medicine through personalization, diagnostics, and continuous patient feedback loops. Key Discussion Points: Hervé describes how Chinese manufacturers had clear long term plans and executed factory builds with extreme speed, noting that today’s outcomes were “already written in the plan” when he left in 1999. He explains how his career evolved from chemical reactors and greenfield factories to designing complex bioprocessing plants and eventually bringing robotics into life sciences where adoption was once minimal. Hervé defines TechBio as engineering applied to biology, shifting from large bioreactors toward individualized therapies like cell and gene treatments where one vial can mean one patient.